Take-Two's Chief Executive Sold About $10.1m of Stock. We Read the Filings

Take-Two's chairman and chief executive, Strauss Zelnick, reported the sale of 40,000 shares of Take-Two stock on 10 August 2026, for a total of about $10.1m. The filings recording that sale do not claim a Rule 10b5-1 trading plan, and two Take-Two directors who sold the following week filed forms that do. Read the next paragraph before the rest of this article. Open market share sales by executives are routine. Executives sell shares for tax, diversification and philanthropic reasons that have nothing whatever to do with a view on the business, and a chief executive selling stock in the run-up to a major product launch is an entirely ordinary event. Nothing in this article is evidence of wrongdoing, and no regulator has alleged any. An unchecked affirmation box on a form does not establish that no plan existed; it establishes only that the filer did not make that affirmation on that form. That narrow point is what makes the contrast with two contemporaneous director filings reportable, and it is not anything more than that. We are also going to say plainly, up front, what we are not saying. The sale happened on 10 August. The Extended Look premiered on 27 August. The filings do not claim a trading plan. Those three facts sit next to each other and we draw no causal line between any two of them. What did Strauss Zelnick actually sell? CONFIRMED from the Form 4 XML, which we parsed rather than reading a summary of. Accession 0000946581-26-000069, period of report 10 August 2026, signed 11 August. The reporting owner is listed as chairman and chief executive, and as both a director and an officer of the company. The 40,000 shares are not one block. They are 13 separate sale lines, all dated 10 August 2026, split by price increment, across two trusts, at prices running from roughly $250.16 to $255.33. All holdings are reported as indirect, and the filer disclaims beneficial ownership except to the extent of his pecuniary interest. 30,000 shares sold from The Zelnick/Belzberg Living Trust, across six price bands: 1,926 at $250.49; 6,007 at $251.62; 10,402 at $252.60; 9,565 at $253.33; 2,000 at $254.45; and 100 at $255.05. 10,000 shares gifted the same day from the Living Trust to The Zelnick/Belzberg Charitable Trust, recorded under transaction code G, and then sold from the charitable trust across five bands: 4,500 at $251.51; 1,600 at $252.47; 1,600 at $253.42; 2,000 at $254.43; and 300 at $255.12. The transaction lines add up to about $10,105,591.73. Several of them are weighted average prices, as the filing's own footnotes explain, which is why a share count multiplied by a headline price will not reproduce the total exactly. Describing this as "sold 40,000 shares" is accurate in aggregate; saying that the shares sat in two trusts and that a quarter of them moved to a charitable trust the same day costs one sentence and is more accurate. Why does the Form 144 say $10,142,800? Because the two documents are answering different questions, and a reader comparing them should not conclude that anybody got it wrong. CONFIRMED. The matching Form 144 states an aggregate market value of $10,142,800, about $37,000 more than the Form 4 lines total. A Form 144 is a notice of proposed sale and carries an estimate of value at the time of filing. A Form 4 reports what actually executed. The gap between an estimate and an execution across 40,000 shares in a moving market is unremarkable, and throughout this article we use about $10.1m, which is the Form 4 figure rounded. The Form 144 also records the broker as Goldman Sachs & Co. LLC, the exchange as NASD, and the shares outstanding as 186,980,443. Its remarks field describes the two-trust structure in the filer's own words, and it corroborates the Form 4 line items exactly. Every image on this page is official Rockstar material. Nothing on this page comes from leaked material, and we did not view any. What is the Rule 10b5-1 affirmation, and what does this filing say? Rule 10b5-1 lets an insider set up a written trading plan in advance, at a time when they hold no material non-public information, and then sell on that schedule. It is the standard mechanism by which executives sell stock without the timing of each sale being a question. Form 4 carries an optional checkbox by which a filer affirms that a reported transaction was made under such a plan. CONFIRMED, re-verified independently by our fact checker against the XML. On this Form 4 the affirmation element reads aff10b5One value 0. Unchecked. And no footnote anywhere in the filing refers to a trading plan; all fourteen footnotes concern weighted average price ranges and disclaimers of beneficial ownership. On the matching Form 144, the planAdoptionDates element is present and empty, a self-closing tag with no date inside it. CONFIRMED, and this is the contrast that makes it reportable. Two Take-Two directors filed Form 4s the following week which do carry the affirmation, with footnotes naming the plan: Michael Sheresky, director. Form 4 accession 0000946581-26-000071, aff10b5One value 1, footnote stating the transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on 18 November 2025. His Form 144 carries the same plan adoption date in its own field. Ellen F. Siminoff, director. Form 4 accession 0000946581-26-000075, aff10b5One value 1, footnote citing a plan adopted by the D&E Living Trust and the EFS 2020 Irrevocable Trust on 19 February 2026. Same company, same week, same form, and the affirmation is made on two of them and not on the third. Did Take-Two disclose a plan anywhere else? We went looking, because a Form 4 checkbox is a weak instrument on its own. Under Item 408 of Regulation S-K, a company must disclose in each periodic report every Section 16 officer or director who adopted, modified or terminated a trading arrangement during that quarter. We read four of them. FilingPeriod coveredWho is named 10-Qquarter ended 30 September 2025nobody, a nil quarter 10-Qquarter ended 31 December 2025ZMC Advisors, L.P., plus Michael Sheresky, Karl Slatoff and William "Bing" Gordon 10-K, Item 9Bquarter ended 31 March 2026Ellen Siminoff and Daniel Emerson 10-Qquarter ended 30 June 2026Lainie Goldstein and William "Bing" Gordon CONFIRMED, and this needs to be read carefully. Strauss Zelnick's name does appear, once, in the 10-Q for the quarter ended 31 December 2025. He is named descriptively. The entity that adopted the plan is ZMC Advisors, L.P., and the filing identifies him as a partner of ZMC in order to explain ZMC's relationship to the company. He is not named as having personally adopted, modified or terminated any arrangement in any of the four filings we read. Three things on the face of that disclosure mean the ZMC plan does not fit the August sale, and we are setting out all three rather than picking the strongest: The adopter is wrong. The plan permits ZMC Advisors to sell. The 10 August sale was made by The Zelnick/Belzberg Living Trust and The Zelnick/Belzberg Charitable Trust, which are different holders. The dates are wrong. The plan's stated maximum duration ran until 12 June 2026. The sale was on 10 August 2026, roughly two months later. The purpose and size are wrong. The plan covers 49.9 per cent of the shares vesting on 1 June 2026 under certain restricted stock units, in order to satisfy the tax obligations arising from that vesting. One coincidence, stated and left alone. The Form 144 records that 30,000 of the August shares were acquired on 1 June 2026 as restricted stock unit compensation, which is the same vesting date the ZMC plan refers to. That is a common annual vesting event and the Form 144 attributes the acquisition to the reporting person rather than to ZMC. The dates coincide. We build nothing on it. What this does not establish This section matters more than the ones above it, and it is where most coverage of filings of this kind goes wrong. Item 408 is a quarterly snapshot, not a register. It requires disclosure only of arrangements adopted, modified or terminated during the quarter covered. A plan adopted in a quarter we did not read simply would not appear in these documents, however carefully we read them. We read four periods, not continuous coverage. The quarters ended 30 September 2025, 31 December 2025, 31 March 2026 and 30 June 2026. Nothing before September 2025 was checked. The 10-K's Item 9B covers only the fourth fiscal quarter, 1 January to 31 March 2026, and not the whole financial year. "The annual report" sounds broader than that disclosure actually is, and we are not going to let it. Plans predating the disclosure regime leave no trace. Item 408 obligations took effect for periodic reports covering periods from 2023 onwards. Anything older has no footprint here at all. An unchecked affirmation box is not a statement that no plan exists. It is an optional affirmation used to claim the Rule 10b5-1(c) affirmative defence. Filers do leave it unchecked for sales made outside a plan for entirely ordinary reasons. Searching for one name is not a complete test. Because this executive's compensation runs through ZMC Advisors under a management agreement, arrangements touching his interests can be adopted at the entity level, as the December quarter shows, and an entity-level plan is disclosed under the entity's name. So the safe formulation, and the one we will stand behind: in the four periodic reports we reviewed, Take-Two did not disclose the adoption of a Rule 10b5-1 trading arrangement by Mr Zelnick personally, and the only plan in those filings connected to him was adopted by ZMC Advisors, L.P., ran to 12 June 2026 and covered shares vesting on 1 June 2026. We are not writing that he had no trading plan. The record we checked does not support that sentence, and we would have to have checked a great deal more to write it. We made no approach to Take-Two for comment on this piece, and we are telling you that rather than leaving you to assume we did. How does this compare with earlier sales? CONFIRMED, from the mandatory prior-sales disclosure in the same Form 144. Three further disposals, all dated 26 May 2026: The Zelnick/Belzberg Living Trust, 44,292 shares for $9,831,797.60; the Wendy Jay Belzberg 2012 Family Trust, 5,708 shares for $1,271,505.57; and The Zelnick/Belzberg Charitable Trust, 20,000 shares for $4,447,792.35. That is 70,000 shares for $15,551,095.52 in May, and 40,000 shares for about $10.1m in August, giving 110,000 shares for roughly $25.66m in the three months to 10 August 2026, per the filings themselves. What is on the calendar next Two dates from Take-Two's own filings, and neither carries any insinuation. CONFIRMED. The trading plan adopted by the chief financial officer, Lainie Goldstein, on 17 June 2026 permits the sale of up to 50,259 shares, runs to 17 September 2027 at the latest, and its first trade cannot occur before 17 September 2026. That is the same calendar day as Take-Two's annual meeting, which is scheduled for 17 September 2026 at 9:00 a.m. Eastern, held virtually and audio only, with a record date of 23 July 2026. Separately, the plan adopted by the director William "Bing" Gordon on 23 June 2026 permits up to 40,000 shares and its first trade cannot occur before 29 September 2026. What is and is not established CONFIRMED from the Form 4 XML: 40,000 shares sold on 10 August 2026 across 13 price banded lines and two trusts, all indirect, totalling about $10,105,591.73, including 10,000 shares gifted the same day from a living trust to a charitable trust and sold from there. CONFIRMED and explained rather than reported as a discrepancy: the Form 144 gives an aggregate market value of $10,142,800, because a Form 144 is a notice of proposed sale carrying an estimate and a Form 4 reports what executed. CONFIRMED, re-verified: the Form 4's Rule 10b5-1 affirmation is unchecked and no footnote in it references a trading plan; the Form 144's plan adoption dates element is empty. CONFIRMED: two Take-Two directors filed Form 4s the following week which do carry the affirmation, citing plans adopted on 18 November 2025 and 19 February 2026. CONFIRMED, and stated precisely: across four periodic reports, the only trading arrangement naming Mr Zelnick was adopted by ZMC Advisors, L.P., ran to 12 June 2026 and covered 49.9 per cent of restricted stock units vesting on 1 June 2026 for tax purposes. Explicitly not claimed: that no plan existed. Item 408 captures only arrangements adopted, modified or terminated within a quarter, we read four quarters, the 10-K item covers one quarter rather than a year, and entity-level plans are disclosed under the entity's name. Explicitly not claimed: any connection between the sale and the Extended Look. The sale was on 10 August, the premiere was on 27 August, and the filings do not claim a trading plan. Stated for the reader: executives sell for tax, diversification and philanthropic reasons; nothing here is evidence of wrongdoing; no regulator has alleged any; and we made no approach to Take-Two for comment. Every document referenced above is free to read on the SEC's EDGAR system, and we would rather you checked the filings than took our arithmetic on trust. More of this on the news page, and if you would rather think about Leonida than about Regulation S-K, our servers list is the better tab.